Problematic detoxification of estrogen quinones by NAD(P)H-dependent quinone oxidoreductase and glutathione-S-transferase

Chemical Research in Toxicology

Volumn 21, Issue 7, 2008, Pages 1324-1329

  Chandrasena, R Esala P ^a   Edirisinghe, Praneeth D ^a   Bolton, Judy L ^a   Thatcher, Gregory R J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GLUTATHIONE TRANSFERASE; OXIDOREDUCTASE; QUINONE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ARTICLE; CARCINOGENESIS; DETOXIFICATION; DNA ADDUCT; HYPOTHESIS; MICHAEL ADDITION;

DNA ADDUCTS; DNA DAMAGE; ESTROGENS, CATECHOL; GLUTATHIONE TRANSFERASE; HUMANS; METABOLIC DETOXICATION, DRUG; NAD(P)H DEHYDROGENASE (QUINONE);

EID: 49049114502     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx8000797     Document Type: Article

References (41)

1. Liehr, J. G. (1990) Genotoxic effects of estrogens. Mutat. Res. 238, 269-276.
2. Feigelson, H. S., and Henderson, B. E. (1996) Estrogens and breast cancer. Carcinogenesis 17, 2279-2284.
3. Yager, J. D., and Davidson, N. E. (2006) Estrogen carcinogenesis in breast cancer. N. Engl. J. Med. 354, 270-282.
4. Rossouw, J. E., Anderson, G. L., Prentice, R. L., LaCroix, A. Z., Kooperberg, C., Stefanick, M. L., Jackson, R. D., Beresford, S. A., Howard, B. V., Johnson, K. C., Kotchen, J. M., and Ockene, J. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial. J. Am. Med. Assoc. 288, 321-333.
5. Beral, V. (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362, 419-427.
6. Chang, M., Peng, K. W., Kastrati, I., Overk, C. R., Qin, Z. H., Yao, P., Bolton, J. L., and Thatcher, G. R. (2007) Activation of estrogen receptor-mediated gene transcription by the equine estrogen metabolite, 4-methoxyequilenin, in human breast cancer cells. Endocrinology 148, 4793-4802.
7. Liehr, J. G. (2001) Genotoxicity of the steroidal oestrogens oestrone and oestradiol: Possible mechanism of uterine and mammary cancer development. Hum. Reprod. Update 7, 273-281.
8. Bolton, J. L., Pisha, E., Zhang, F., and Qiu, S. (1998) Role of quinoids in estrogen carcinogenesis. Chem. Res. Toxicol. 11, 1113-1127.
9. Bolton, J. L., Yu, L., and Thatcher, G. R. J. (2004) Quinoids formed from estrogens and antiestrogens. Methods Enzymol. 378, 110-123.
10. Cavalieri, E., Chakravarti, D., Guttenplan, J., Hart, E., Ingle, J., Jankowiak, R., Muti, P., Rogan, E., Russo, J., Santen, R., and Sutter, T. (2006) Catechol estrogen quinones as initiators of breast and other human cancers: Implications for biomarkers of susceptibility and cancer prevention. Biochim. Biophys. Acta 1766, 63-78.
11. Cavalieri, E., Frenkel, K., Liehr, J. G., Rogan, E., and Roy, D. (2000) Estrogens as endogenous genotoxic agents - DNA adducts and mutations. J. Natl. Cancer Inst. Monogr. 11, 75-93.
12. Zhu, B. T., and Conney, A. H. (1998) Functional role of estrogen metabolism in target cells: Review and perspectives. Carcinogenesis 19, 1-27.
13. Zhu, B. T., and Liehr, J. G. (1996) Inhibition of catechol O-methyltransferase-catalyzed O-methylation of 2- and 4-hydroxyestradiol by quercetin. Possible role in estradiol-induced tumorigenesis. J. Biol. Chem. 271, 1357-1363.
14. Montano, M. M., Chaplin, L. J., Deng, H., Mesia-Vela, S., Gaikwad, N., Zahid, M., and Rogan, E. (2007) Protective roles of quinone reductase and tamoxifen against estrogen-induced mammary tumorigenesis. Oncogene 26, 3587-3590.
15. Gaikwad, N. W., Rogan, E. G., and Cavalieri, E. L. (2007) Evidence from ESI-MS for NQO1-catalyzed reduction of estrogen orthoquinones. Free Radical Biol. Med. 43, 1289-1298.
16. Saeed, M., Rogan, E., Fernandez, S. V., Sheriff, F., Russo, J., and Cavalieri, E. (2007) Formation of depurinating N3Adenine and N7Guanine adducts by MCF-10F cells cultured in the presence of 4-hydroxyestradiol. Int. J. Cancer 120, 1821-1824.
17. Stack, D. E., Byun, J., Gross, M. L., Rogan, E. G., and Cavalieri, E. L. (1996) Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides. Chem. Res. Toxicol. 9, 851-859.
18. Zahid, M., Kohli, E., Saeed, M., Rogan, E., and Cavalieri, E. (2006) The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: Implications for tumor-initiating activity. Chem. Res. Toxicol. 19, 164-172.
19. Li, K. M., Todorovic, R., Devanesan, P., Higginbotham, S., Kofeler, H., Ramanathan, R., Gross, M. L., Rogan, E. G., and Cavalieri, E. L. (2004) Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo. Carcinogenesis 25, 289-297.
20. Montano, M. M., Bianco, N. R., Deng, H., Wittmann, B. M., Chaplin, L. C., and Katzenellenbogen, B. S. (2005) Estrogen receptor regulation of quinone reductase in breast cancer: Implications for estrogen-induced breast tumor growth and therapeutic uses of tamoxifen. Front. Biosci. 10, 1440-1461.
21. Cornblatt, B. S., Ye, L., Dinkova-Kostova, A. T., Erb, M., Fahey, J. W., Singh, N. K., Chen, M. S., Stierer, T., Garrett-Mayer, E., Argani, P., Davidson, N. E., Talalay, P., Kensler, T. W., and Visvanathan, K. (2007) Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. Carcinogenesis 28, 1485-1490.
22. Nutter, L. M., Zhou, B., Sierra, E. E., Wu, Y. Y., Rummel, M. M., Gutierrez, P., and Abul-Hajj, Y. (1994) Cellular biochemical determinants modulating the metabolism of estrone 3,4-quinone. Chem. Res. Toxicol. 7, 609-613.
23. Shen, L., Pisha, E., Huang, Z., Pezzuto, J. M., Krol, E., Alam, Z., van Breemen, R. B., and Bolton, J. L. (1997) Bioreductive activation of catechol estrogen-ortho-quinones: Aromatization of the B ring in 4-hydroxyequilenin markedly alters quinoid formation and reactivity. Carcinogenesis 18, 1093-1101.
24. Chang, M., Bolton, J. L., and Blond, S. Y. (1999) Expression and purification of hexahistidine-tagged human glutathione S-transferase P1-1 in Escherichia coli. Protein Expression Purif. 17, 443-448.
25. Abul-Hajj, Y. J., and Cisek, P. L. (1986) Regioselective reaction of thiols with catechol estrogens and estrogen-O-quinones. J. Steroid Biochem. 25, 245-247.
26. Iverson, S. L., Shen, L., Anlar, N., and Bolton, J. L. (1996) Bioactivation of estrone and its catechol metabolites to quinoid-glutathione conjugates in rat liver microsomes. Chem. Res. Toxicol. 9, 492-499.
27. Bolton, J. L., and Shen, L. (1996) p-Quinone methides are the major decomposition products of catechol estrogen o-quinones. Carcinogenesis 17, 925-929.
28. Salvador, A., and Savageau, M. A. (2003) Quantitative evolutionary design of glucose 6-phosphate dehydrogenase expression in human erythrocytes. Proc. Natl. Acad. Sci. U.S.A. 100, 14463-14468.
29. Jiang, Z. Q., Chen, C., Yang, B., Hebbar, V., and Kong, A. N. (2003) Differential responses from seven mammalian cell lines to the treatments of detoxifying enzyme inducers. Life Sci. 72, 2243-2253.
30. Yu, B., Dietz, B. M., Dunlap, T., Kastrati, I., Lantvit, D. D., Overk, C. R., Yao, P., Qin, Z., Bolton, J. L., and Thatcher, G. R. (2007) Structural modulation of reactivity/activity in design of improved benzothiophene selective estrogen receptor modulators: induction of chemopreventive mechanisms. Mol. Cancer Ther. 6, 2418-2428.
31. Hagos, G. K., Carroll, R. E., Kouznetsova, T., Li, Q., Toader, V., Fernandez, P. A., Swanson, S. M., and Thatcher, G. R. (2007) Colon cancer chemoprevention by a novel NO chimera that shows anti-inflammatory and antiproliferative activity in vitro and in vivo. Mol. Cancer Ther. 6, 2230-2239.
32. Liu, J., Li, Q., Yang, X., van Breemen, R. B., Bolton, J. L., and Thatcher, G. R. J. (2005) Analysis of protein covalent modification by xenobiotics using a covert oxidatively activated tag: Raloxifene proof-of-principle study. Chem. Res. Toxicol. 18, 1485-1496.
33. Singh, S., Chakravarti, D., Edney, J. A., Hollins, R. R., Johnson, P. J., West, W. W., Higginbotham, S. M., Cavalieri, E. L., and Rogan, E. G. (2005) Relative imbalances in the expression of estrogen-metabolizing enzymes in the breast tissue of women with breast carcinoma. Oncol. Rep. 14, 1091-1096.
34. Huggins, C., and Fukunishi, R. (1964) Induced protection of adrenal cortex against 7,12-dimethylbenz(alpha)anthracene. Influence of ethionine. Induction of menadione reductase. Incorporation of thymidine-H3. J. Exp. Med. 119, 923-942.
35. Menzel, H. J., Sarmanova, J., Soucek, P., Berberich, R., Grunewald, K., Haun, M., and Kraft, H. G. (2004) Association of NQO1 polymorphism with spontaneous breast cancer in two independent populations. Br. J. Cancer 90, 1989-1994.
36. Begleiter, A., Hewitt, D., Maksymiuk, A. W., Ross, D. A., and Bird, R. P. (2006) A NAD(P)H:quinone oxidoreductase 1 polymorphism is a risk factor for human colon cancer. Cancer Epidemiol. Biomarkers Prev. 15, 2422-2426.
37. Chao, C., Zhang, Z. F., Berthiller, J., Boffetta, P., and Hashibe, M. (2006) NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: A meta-analysis. Cancer Epidemiol. Biomarkers Prev. 15, 979-987.
38. Ross, D., and Siegel, D. (2004) NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics. Methods Enzymol. 382, 115-144.
39. Siegel, D., Gustafson, D. L., Dehn, D. L., Han, J. Y., Boonchoong, P., Berliner, L. J., and Ross, D. (2004) NAD(P)H:quinone oxidoreductase 1: Role as a superoxide scavenger. Mol. Pharmacol. 65, 1238-1247.
40. Asher, G., Lotem, J., Cohen, B., Sachs, L., and Shaul, Y. (2001) Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1. Proc. Natl. Acad. Sci. U.S.A. 98, 1188-1193.
41. Bianco, N. R., Chaplin, L. J., and Montano, M. M. (2005) Differential induction of quinone reductase by phytoestrogens and protection against oestrogen-induced DNA damage. Biochem. J. 385, 279-287.